Felodipine (Agon)

486  relevant articles (57 outcomes, 135 trials/studies) found for this Drug

Agon; 1A Brand of Felodipine; AbZ Brand of Felodipine; Aliud Brand of Felodipine; Alphapharm Brand of Felodipine; Alpharma Brand of Felodipine; Astra Brand of Felodipine; AstraZeneca Brand of Felodipine; Aventis Brand of Felodipine; Azupharma Brand of Felodipine; BC Brand of Felodipine; Felo Biochemie; Felo-Puren; Felobeta; Felocor; Felodipin 1A Pharma; Felodipin AL; Felodipin AZU; Felodipin AbZ; Felodipin Heumann; Felodipin Stada; Felodipin dura; Felodipin-ratiopharm; Felodur; Felogamma; Fensel; Flodil; H 154-82; Heumann Brand of Felodipine; Hexal Brand of Felodipine; Hoechst Brand of Felodipine; Merck dura Brand of Felodipine; Modip; Munobal; Perfudal; Pharmaceutica Astra Brand of Felodipine; Pharmacia Spain Brand of Felodipine; Plendil; Promed Brand of Felodipine; Renedil; Stadapharm Brand of Felodipine; TheraPharm Brand of Felodipine; Wörwag Brand of Felodipine; betapharm Brand of Felodipine; ct-Arzneimittel Brand of Felodipine; felodipin von ct; ratiopharm Brand of Felodipine; Felo Puren; Felodipin ratiopharm; H 154 82; H 15482; Heumann, Felodipin; ct Arzneimittel Brand of Felodipine; 3,5-Pyridinedicarboxylic acid, 4-(2,3-dichlorophenyl)-1,4-dihydro-2,6-dimethyl-, ethyl methyl ester

Relationship Network

Drug Context: Research Results

Experts

1.	Zhang, Yun: 3 articles (09/2008 - 01/2008)
2.	Tan, Hong-Wei: 2 articles (09/2008 - 07/2008)
3.	Zhong, Ming: 2 articles (09/2008 - 07/2008)
4.	Bi, Xiu-Ping: 2 articles (09/2008 - 07/2008)
5.	Zhang, Wei: 2 articles (09/2008 - 07/2008)
6.	Xing, Shan-Shan: 2 articles (09/2008 - 07/2008)
7.	Taylor, W R: 2 articles (06/2000 - 03/2000)
8.	Cohn, J N: 2 articles (06/2000 - 03/2000)
9.	Germanson, T: 2 articles (06/2000 - 03/2000)
10.	Wong, M: 2 articles (06/2000 - 03/2000)

Related Diseases

1.	Hypertension (High Blood Pressure) 01/01/1990 - "It is concluded that felodipine decreases BP dramatically in patients with previously refractory hypertension and that the drug causes an improved renal function in these patients." 07/01/1996 - "CONCLUSIONS: Felodipine is effective in the treatment of elders with essential hypertension." 08/01/1995 - "These data suggest that once a day felodipine is effective in children with hypertension" 12/01/1992 - "In conclusion, we found felodipine given once daily to be effective in the treatment of mild to moderate hypertension." 05/01/1998 - "The authors conclude that felodipine is useful for the treatment of mild essential hypertension, since it reduces arterial resistance without altering venous capacitance or distensibility." Order ALL the reference details at left...
2.	Heart Failure 12/01/1989 - "In conclusion, felodipine was of benefit in congestive heart failure at rest in an acute test, acting through a marked decrease in vascular resistance and a consequent improvement in cardiac output and limb blood flow" 11/01/1987 - "Efficacy of felodipine in chronic congestive heart failure: a placebo controlled haemodynamic study at rest and during exercise and orthostatic stress." 01/01/1991 - "Acute and chronic efficacy of felodipine in congestive heart failure." 04/01/1989 - "Efficacy of felodipine in congestive heart failure." 11/01/1987 - "Thus three weeks treatment with felodipine improved haemodynamic function at rest and during standard exercise and normalised the baroreflex mediated haemodynamic response in patients with congestive heart failure" Order ALL the reference details at left...
3.	Angina Pectoris 11/01/1991 - "The efficacy of felodipine in the management of chronic stable angina pectoris and CHF requires further investigation." 11/01/1991 - "Evaluations of patients with chronic stable angina are limited, and additional studies are needed before felodipine can be recommended for the routine management of angina pectoris" 11/01/1995 - "Felodipine in addition to beta-adrenergic blockade for angina pectoris" 08/15/1991 - "Twenty-four-hour activity of felodipine extended release in chronic stable angina pectoris." 01/01/1990 - "The effects of felodipine in angina pectoris." Order ALL the reference details at left...
4.	Hyperemia 07/01/1993 - "Mucosal hyperemia and tachycardia, as an expression of the vasodilating properties of felodipine, were observed in a somewhat variable but dose-related manner" 05/01/1996 - "During 30 minutes of reperfusion, felodipine had a beneficial effect upon coronary blood flow (initial postischemic hyperemia 245 +/- 38% of baseline in the felodipine group vs. 124 +/- 18% in the controls; p < 0.01) Felodipine markedly improved the recovery of contractile function [LV developed pressure recovered from a baseline of 104 +/- 4 to 75 +/- 6 mmHg (72%) in the felodipine group vs. 34 +/- 10 mmHg (32%) in the control group; p < 0.01], as well as diastolic function (LVEDP = 25 +/- 4 mmHg in the felodipine group vs. 61 +/- 10 mmHg in the controls; p < 0.05), and ATP levels (8.5 +/- 1.4 mumoles/g d.w" 01/20/2006 - "FBF during reactive hyperemia was significantly improved by candesartan in patients without HRT (hyperemic peak flow and area under the FBF curve), whereas felodipine and placebo exerted no effect" 07/01/2002 - "FBF during reactive hyperemia was significantly improved by candesartan, whereas felodipine and placebo exerted no effect" Order ALL the reference details at left...
5.	Left Ventricular Hypertrophy (Ventricular Hypertrophy, Left) 11/01/2001 - "To compare the effects of active treatment compared with placebo on blood pressure, left ventricular hypertrophy, and quality of life among older stage 1 isolated systolic hypertensive patients, a randomized, double-blind, parallel-group, multicenter clinical trial comparing felodipine (2.5, 5, or 10 mg once daily) and matching placebo was performed in 171 patients (49% male, average age 66+/-7 years, with 49% white and 30% Hispanic) with a baseline blood pressure of 149+/-7/83+/-6 mm Hg. During 52 weeks of treatment, patients randomized to active treatment achieved significantly lower blood pressures (137.0+/-11.7/80.2+/-7.6 mm Hg for extended-release felodipine versus 147.5+/-16.0/83.5+/-9.7 mm Hg for placebo, P<0.01 for each), a reduced incidence of left ventricular hypertrophy (7% for extended release felodipine versus 24% for placebo, P<0.04), and improved quality of life (change in Psychological General Well-Being index, 3.0+/-6.8 for extended-release felodipine versus -0.8+/-10.3 for placebo, P<0.01) versus baseline" 11/01/1994 - "Clinical studies show that antihypertensive treatment with felodipine promotes regression of left ventricular hypertrophy, increases compliance of large arteries, and has favourable effects on renal function" 08/01/1992 - "In addition to its antihypertensive action, results suggest that felodipine therapy is associated with significant regression of left ventricular hypertrophy" 03/01/1992 - "Antihypertensive effect of felodipine associated with persistent sympathetic activation and minimal regression of left ventricular hypertrophy." 09/01/1996 - "The efficacy of felodipine ER on regression of left ventricular hypertrophy in patients with primary hypertension." Order ALL the reference details at left...

Related Drugs and Biologics

1.	Calcium
2.	1,4-dihydropyridine (dihydropyridine)
3.	Metoprolol (Lopressor)
4.	Nitrendipine
5.	Isradipine (Dynacirc)
6.	Verapamil (Calan)
7.	Nifedipine (Adalat)
8.	Amlodipine (Norvasc)
9.	Enalapril
10.	Calcium Channels (Calcium Channel)

Related Therapies and Procedures

1.	Ligation
2.	Exercise (Aerobic Exercise)
3.	Transplantation (Transplant Recipients)
4.	Surgical Instruments (Clip)
5.	Drug Prescriptions (Prescription, Drug)